ID   2A5 [Mouse hybridoma against human GRN]
AC   CVCL_X853
DR   ATCC; PTA-5589
DR   Wikidata; Q54584295
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5589.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
RX   Patent=US7091047;
RA   Serrero G.;
RT   "Methods and kits for diagnosing tumorigenicity.";
RL   Patent number US7091047, 15-Aug-2006.
//
RX   Patent=US7368428;
RA   Serrero G.;
RT   "Contacting tumor cells to glycoprotein 88 (GP88) antagonists (e.g.,
RT   anti-GP88 antibodies, anti-GP88 antisense nucleic acids, GP88 siRNA,
RT   and small molecules); antiestrogen and cytotoxic therapy.";
RL   Patent number US7368428, 06-May-2008.
//
RX   Patent=US7674460;
RA   Serrero G.;
RT   "Compositions and methods for restoring sensitivity to treatment with
RT   HER2 antagonists.";
RL   Patent number US7674460, 09-Mar-2010.
//